Clinical outcomes of radiofrequency ablation for solitary T1aN0M0 versus T1bN0M0 papillary thyroid carcinoma: a propensity-matched cohort study

References

• Zafon C, Baena JA, Castellvi J, et al. Differences in the form of presentation between papillary microcarcinomas and papillary carcinomas of larger size. J Thyroid Res. 2010;2011:639156. doi: 10.4061/2011/639156.
   PubMedGoogle Scholar
• Mazeh H, Chen H. Advances in surgical therapy for thyroid cancer. Nat Rev Endocrinol. 2011;7(10):581–588. doi: 10.1038/nrendo.2011.140.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27–34. doi: 10.1089/thy.2013.0367.
   PubMed Web of Science ®Google Scholar
• Kim JH, Baek JH, Lim HK, et al. 2017 Thyroid radiofrequency ablation guideline: Korean society of thyroid radiology. Korean J Radiol. 2018;19(4):632–655. doi: 10.3348/kjr.2018.19.4.632.
   PubMed Web of Science ®Google Scholar
• Tian H, Ma N, Xu D, et al. Analysis of therapeutic effect of ultrasound-guided radiofrequency ablation for thyroid microcarcinoma. Chin J Med Imaging Technol. 2018;34(4):514–517. doi: 10.13929/j.1003-3289.201708154.
   Google Scholar
• Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016;26(11):1581–1587. doi: 10.1089/thy.2015.0471.
   PubMed Web of Science ®Google Scholar
• Kim JH, Baek JH, Sung JY, et al. Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery. Int J Hyperthermia. 2017;33(2):212–219. doi: 10.1080/02656736.2016.1230893.
   PubMed Web of Science ®Google Scholar
• Jeong SY, Baek JH, Choi YJ, et al. Radiofrequency ablation of primary thyroid carcinoma: efficacy according to the types of thyroid carcinoma. Int J Hyperthermia. 2018;34(5):611–616. doi: 10.1080/02656736.2018.1427288.
   PubMed Web of Science ®Google Scholar
• Luo Y, Zhang M. Ultrasound-guided radiofrequency ablation of low-risk papillary thyroid microcarcinoma: a prospective study. Ultrasound Med Biol. 2017;43(:S240–S241. doi: 10.1016/j.ultrasmedbio.2017.08.1841.
   Google Scholar
• Lim HK, Baek SM, Baek JH. US-guided radiofrequency ablation for primary thyroid cancer: efficacy and safety of long-term follow-up in a large population. Neuroradiology. 2018;60(1):271.
   Google Scholar
• Li J, Liu Y, Liu J, et al. A comparative study of short-term efficacy and safety for thyroid micropapillary carcinoma patients after microwave ablation or surgery. Int J Hyperthermia. 2019;36(1):640–646. doi: 10.1080/02656736.2019.1626492.
   PubMed Web of Science ®Google Scholar
• Teng D, Sui G, Liu C, et al. Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study. J Cancer Res Clin Oncol. 2018;144(4):771–779. doi: 10.1007/s00432-018-2607-7.
   PubMed Web of Science ®Google Scholar
• Teng DK, Li HQ, Sui GQ, et al. Preliminary report of microwave ablation for the primary papillary thyroid microcarcinoma: a large-cohort of 185 patients feasibility study. Endocrine. 2019;64(1):109–117. doi: 10.1007/s12020-019-01868-2.
   PubMed Web of Science ®Google Scholar
• Yue W, Wang S, Yu S, et al. Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience. Int J Hyperthermia. 2014;30(2):150–157. doi: 10.3109/02656736.2014.885590.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhou W, Zhan W, et al. Percutaneous laser ablation of unifocal papillary thyroid microcarcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in assessing local therapeutic response. World J Surg. 2018;42(8):2476–2484. doi: 10.1007/s00268-018-4500-6.
   PubMed Web of Science ®Google Scholar
• Ji L, Wu Q, Gu J, et al. Ultrasound-guided percutaneous laser ablation for papillary thyroid microcarcinoma: a retrospective analysis of 37 patients. Cancer Imaging. 2019;19(1):16. doi: 10.1186/s40644-019-0204-x.
   PubMed Web of Science ®Google Scholar
• Tong M, Li S, Li Y, et al. Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2019;36(1):1278–1286. doi: 10.1080/02656736.2019.1700559.
   PubMed Web of Science ®Google Scholar
• Tuttle RM, Haugen B, Perrier ND. Updated American joint committee on cancer/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): what changed and why? Thyroid. 2017;27(6):751–756. doi: 10.1089/thy.2017.0102.
   PubMed Web of Science ®Google Scholar
• Sakai T, Sugitani I, Ebina A, et al. Active surveillance for T1bN0M0 papillary thyroid carcinoma. Thyroid. 2019;29(1):59–63. doi: 10.1089/thy.2018.0462.s
   PubMed Web of Science ®Google Scholar
• Anderson KL, Jr., Youngwirth LM, Scheri RP, et al. T1a versus T1b differentiated thyroid cancers: do We need to make the distinction? Thyroid. 2016;26(8):1046–1052. doi: 10.1089/thy.2016.0073.
   PubMed Web of Science ®Google Scholar
• Papini E, Guglielmi R, Gharib H, et al. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid. 2011;21(8):917–920. doi: 10.1089/thy.2010.0447.
   PubMed Web of Science ®Google Scholar
• Cao XJ, Liu J, Zhu YL, et al. Efficacy and safety of thermal ablation for solitary T1bN0M0 papillary thyroid carcinoma: a multicenter study. J Clin Endocrinol Metab. 2021;106(2):e573–e581. doi: 10.1210/clinem/dgaa776.
   PubMed Web of Science ®Google Scholar
• Cao XJ, Wang SR, Che Y, et al. Efficacy and safety of thermal ablation for treatment of solitary T1N0M0 papillary thyroid carcinoma: a multicenter retrospective study. Radiology. 2021;300(1):209–216. doi: 10.1148/radiol.2021202735.
   PubMed Web of Science ®Google Scholar
• Xiao J, Zhang M, Zhang Y, et al. Efficacy and safety of ultrasonography-guided radiofrequency ablation for the treatment of T1bN0M0 papillary thyroid carcinoma: a retrospective study. Int J Hyperthermia. 2020;37(1):392–398. doi: 10.1080/02656736.2020.1752945.
   PubMed Web of Science ®Google Scholar
• Xiao J, Zhang Y, Yan L, et al. Ultrasonography-guided radiofrequency ablation for solitary T1aN0M0 and T1bN0M0 papillary thyroid carcinoma: a retrospective comparative study. Eur J Endocrinol. 2021;186(1):105–113. doi: 10.1530/EJE-21-0580.
   PubMed Web of Science ®Google Scholar
• Yan L, Li Y, Li XY, et al. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: a retrospective study with more than 5 years of follow-up. Cancer. 2023;129(16):2469–2478. doi: 10.1002/cncr.34802.
   PubMed Web of Science ®Google Scholar
• Yi Z, Siyu L, Lijun F, et al. Efficacy, safety, and controversy of ultrasound-guided radiofrequency ablation in the treatment of T1N0M0 papillary thyroid carcinoma. Front Oncol. 2022;12:1068210. doi: 10.3389/fonc.2022.1068210.
   PubMed Web of Science ®Google Scholar
• Yan L, Li X, Li Y, et al. Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma. Eur Radiol. 2023;33(1):730–740. doi: 10.1007/s00330-022-08963-5.
   PubMed Web of Science ®Google Scholar
• Zheng L, Dou JP, Liu FY, et al. Microwave ablation vs. surgery for papillary thyroid carcinoma with minimal sonographic extrathyroid extension: a multicentre prospective study. Eur Radiol. 2023;33(1):233–243. doi: 10.1007/s00330-022-08962-6.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. doi: 10.1089/thy.2015.0020.
   PubMed Web of Science ®Google Scholar
• Brito JP, Ito Y, Miyauchi A, et al. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. Thyroid. 2016;26(1):144–149. doi: 10.1089/thy.2015.0178.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34(1):28–35. doi: 10.1007/s00268-009-0303-0.
   PubMed Web of Science ®Google Scholar
• Kim C, Lee JH, Choi YJ, et al. Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers. Eur Radiol. 2017;27(8):3128–3137. doi: 10.1007/s00330-016-4690-y.
   PubMed Web of Science ®Google Scholar
• Papaleontiou M, Hughes DT, Guo C, et al. Population-based assessment of complications following surgery for thyroid cancer. J Clin Endocrinol Metab. 2017;102(7):2543–2551. doi: 10.1210/jc.2017-00255.
   PubMed Web of Science ®Google Scholar
• Chung SR, Baek JH, Choi YJ, et al. Management strategy for nerve damage during radiofrequency ablation of thyroid nodules. Int J Hyperthermia. 2019;36(1):204–210. doi: 10.1080/02656736.2018.1554826.
   PubMed Web of Science ®Google Scholar